Scrutinizer Report - Unsecured Trade Creditors
VIYASH · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
SeQuent Scientific Limited held an NCLT-convened meeting of its Unsecured Trade Creditors on August 30, 2025, via video conferencing, to seek approval for a Composite Scheme of Amalgamation involving 10 companies including SeQuent Scientific, Symed Labs, Viyash Life Sciences, and others. Out of 124 unsecured trade creditors who voted, 123 voted in favour (99.97% by value, totalling around Rs 19.17 crore) and only 1 voted against (0.03%). The quorum of 5 was easily met with 20 creditors attending. The resolution was approved with the requisite majority — majority in number representing three-fourths in value — clearing a key creditor-level milestone for the amalgamation scheme. BSE and NSE had already issued observation letters (no-objection) on the scheme in May 2025. Final approval from the NCLT is still pending.
This is a procedural but positive step forward for SeQuent Scientific's proposed amalgamation with multiple group entities. Creditor approval reduces the risk of the scheme being derailed, though the deal still needs final NCLT sanction before becoming effective. No immediate impact on share price is expected from this routine disclosure.